European Basic Pharmaceutical Products Turnover Share by Country (Million Euros)

The European Basic Pharmaceutical Products turnover share shows that in 2024, Switzerland leads with a significant margin, capturing the majority share of 57.84 million Euros. Italy and Spain follow, with performances of 12.04 million Euros and 10.16 million Euros, respectively. Other notable countries include Austria with 5.69 million Euros and Germany at 2.93 million Euros. There is a notable variance among countries, with Greece and Belgium experiencing marked increases, while France saw a decline in turnover share. Belgium and the Netherlands demonstrated substantial year-over-year growth in 2023, with 57.06% and 34.12%, respectively.

Key Trends (Year-over-Year 2023):

• Switzerland: +7.45%
• Italy: +3.89%
• Spain: +3.74%
• Austria: +3.67%
• Germany: +5.76%
• Greece: +8.93%
• Belgium: +57.06%
• Netherlands: +34.12%
• France: -13.33%
• Portugal: +5.66%
• Romania: +2.64%
• Hungary: +3.25%
• Czech Republic: -0.37%
• Poland: +3.3%
• Serbia: +8.74%

Future Trends to Watch:

• Continued dominance of Switzerland in the market, likely driven by innovations and expansions in pharmaceutical R&D.
• Potential for substantial growth in countries with positive trends in 2023, particularly Belgium and the Netherlands.
• Close monitoring required for France to assess the impact of recent declines and strategize recovery.
• Emerging opportunities in smaller markets like Greece and Serbia, reflecting significant year-over-year growth.